To ensure patient access, development and manufacturing cost efficiency can’t be lost to the promise of personalized cancer vaccines. In this segment of the Bioprocess Online Live event, guest experts Peter Berglund, chief scientific officer at HDT Bio, Johanna Kaufmann, EVP for oncology at Codagenix, and Robert Georgantas, president and CTO at Providence Therapeutics weigh in on managing development and manufacturing costs.
Check out the full webinar available on-demand - [ Ссылка ]
![8 HACKERS que CAMBIARON el MUNDO [RECOPILACIÓN]](https://i.ytimg.com/vi/8PN58BEusbE/mqdefault.jpg)
![[Ep. 11] Understand SDL Event with Mouse motion, key presses, keycodes and scancodes | Intro to SDL2](https://i.ytimg.com/vi/EBHmMmiVtCk/mqdefault.jpg)
